Saudi Arabian car rental business Lumi pops 30% in stock industry debut

Saudi Arabian car rental business Lumi pops 30% in stock industry debut


Cityscape of Saudi money Riyadh.

Harri Jarvelainen Photography | Minute | Getty Visuals

Shares of Lumi soared as significantly as 30% on Monday at the Saudi Arabian auto rental business debuted on the Riyadh inventory trade in a 1.09 billion riyal ($290 million) original general public featuring.

A unit of Saudi journey business Seera, Lumi mentioned 30% of its shares on the Saudi Tadawul exchange at an first value of 66 riyals, at the prime of their variety. Selling prices soon right after rose to 85.8 riyals for each share.

In accordance to its original community providing prospectus, Lumi is the third-most significant motor vehicle rental service provider in the Saudi kingdom, capturing an approximated neighborhood industry share of 7% in 2021.

This is a breaking information story, remember to verify back later for a lot more.



Supply

Consumer prices rose 2.4% annually in January, less than expected
World

Consumer prices rose 2.4% annually in January, less than expected

The cost of goods and services rose at a slower annual rate than expected in January, providing hope that the nagging U.S. inflation problem could be starting to ease. The consumer price index for January accelerated 2.4% from the same time a year ago, down 0.3 percentage point from the prior month, the Bureau of […]

Read More
Dubai’s DP World replaces CEO after Epstein links emerge
World

Dubai’s DP World replaces CEO after Epstein links emerge

Sultan Ahmed Bin Sulayem of Dubai speaks at a news conference on Nov. 10, 2005 in New York City. Mario Tama | Getty Images News | Getty Images The CEO of Dubai’s largest port has been replaced by the company after details of his past relationship with the late sex offender Jeffrey Epstein were made […]

Read More
Prices, pipelines and patent cliffs: Inside pharma’s big reset
World

Prices, pipelines and patent cliffs: Inside pharma’s big reset

This earnings season, Europe’s biggest pharma companies posted results ranging from 7% beats to 3% misses — but no one really cared. Instead, drugmakers looked ahead, with 2026 shaping up to be a defining year following a dramatic 2025, and one where the impact from last year’s developments is set to crystallize. “2025 was about […]

Read More